Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
Recruiting
N/A
Interventional Study
Rheumatic Heart Disease
Rheumatic Heart Disease in Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 5 – 16
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 2,300 (estimated)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 5-16 years
* Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.
Exclusion Criteria:
* Children / primary caregivers not providing informed consent to participate
* Children not attending Tulsi Secondary Boarding School in Tulsipur.
Contacts